Philip Morris International (PM) recently reported full year 2025 results showing smoke free products now account for 41.5% of revenue, with brands such as ZYN and IQOS playing a key role in that mix.

The recent full year 2025 update and new partnerships, such as the Ferrari Hypersail project, come after a 10.1% 30 day share price decline and a modest 1.4% 1 year total shareholder return. The 5 year total shareholder return of 111.6% points to strong longer term gains and fading short term momentum.

If Philip Morris' shift toward smoke free products has caught your eye, this can be a good moment to broaden your watchlist with 19 top founder-led companies

With the share price down 10.1% over the past month, yet still showing a 111.6% 5 year total return and a value score of 4, is Philip Morris now trading at a discount or is future growth already priced in?

Most Popular Narrative: 19.5% Undervalued

Philip Morris International's most followed narrative points to a fair value of $195.17 against a last close of $157.19, putting the spotlight firmly on smoke free growth, margin assumptions, and what investors may be willing to pay for those earnings.

The accelerating global adoption of smoke-free alternatives, driven by increasing health awareness and regulatory moves away from combustibles, is fueling strong double-digit volume and margin growth in PMI's IQOS, ZYN, and VEEV platforms. This secular shift enables the company to capture new consumer segments, expand its addressable market, and structurally boost net revenues and operating margins over time.

Curious what level of revenue growth, margin expansion, and future P/E multiple are baked into that fair value? The narrative leans on richer product mix, higher profitability, and a discount rate of 8.07% to get there, all underpinned by analyst expectations for earnings and revenue several years out.

Result: Fair Value of $195.17 (UNDERVALUED)

However, this upbeat narrative still hinges on smoke free products offsetting cigarette declines, and on tighter regulations or taxes not weighing more heavily than analysts expect.

Another View: What The P/E Ratio Is Signalling

On the flip side of that 19.5% undervalued fair value, Philip Morris trades on a P/E of 21.6x versus 12.6x for the global Tobacco industry and 21.4x for peers, while the fair ratio is 26.4x. That mix of premium today and potential headroom raises an obvious question: how much valuation risk are you really comfortable with?

Next Steps

If this mix of optimism and concern leaves you undecided, it can be helpful to review the data yourself and make a timely decision with 5 key rewards and 2 important warning signs

Looking for more investment ideas?

Philip Morris might be on your radar right now, but some of the most interesting opportunities can sit quietly in other corners of the market.

• Spot potential bargains before the crowd by scanning companies that appear mispriced on fundamentals with 60 high quality undervalued stocks.
• Focus on durability and aim to sleep a little easier at night by checking out 72 resilient stocks with low risk scores.
• Hunt for lesser known names with solid metrics and future potential using screener containing 23 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.